DDReg pharma

Quailty Driven by Passion

Submit Query

Case Studies

Home » Case Studies » Page 2

Drug-device registration in CIS countries

All Category, Case Studies, Regulatory /

Customer Requirement: A global Non-profit organization in the area of female health & wellness wanted to obtain drug device registration and market authorization for their contraceptive that included its administration device, in CIS region, including Azerbaijan, Kyrgyzstan and Tajikistan.  The contraceptive was classified as a drug-device combination product for which regulations are challenging to navigate […]

Drug-device registration in CIS countries Read More »

Accelerating access to Women’s Health products

All Category, Case Studies, Regulatory /

Customer Requirement: Women’s health and fertility are vital aspects of their overall well-being, and yet they often remain shrouded in silence and misconception. Every woman has the right to access healthcare, irrespective of their socioeconomic background or geographical location, though many women face significant challenges and barriers that restricts their access to the medications they

Accelerating access to Women’s Health products Read More »

Web-based Lifecycle Management Tool

All Category, Case Studies, Regulatory /

Customer Requirement: A Non-profit organization faced challenges in tracking and monitoring the registration status of their products in respective regions. This is because they had one product  in multiple markets that were each in different stages of their lifecycle. Siloed and disconnected tracking systems meant that the organization was left with little insight into the

Web-based Lifecycle Management Tool Read More »

regulatory publishing

Incorporating plug in tools to facilitate regulatory publishing tasks

All Category, Case Studies, Publishing /

Single bookmarking and hyperlinking tasks were conducted manually by regulatory publishing team members at DDReg which was a repetitive and time-consuming task. The key objective was to implement tools that would automate repetitive tasks to create a more efficient workflow for filing and e-functionality within the organization The regulatory publishing team at DDReg conducted deep

Incorporating plug in tools to facilitate regulatory publishing tasks Read More »

Gulf Health Council file upload

Gulf Health Council file upload for biosimilar product

All Category, Case Studies, Publishing /

One of the top three biopharmaceutical companies approached DDReg to get the dossiers for their product submitted to the Gulf Health Council (GHC). The challenge was to publish and submit the large size files to the GHC portal (Taawon) while running against the time. As the team finished the grueling job of publishing the sections

Gulf Health Council file upload for biosimilar product Read More »

Indian Herbal Pain Patch in the USA

Introduction of Indian Herbal Pain Patch in the USA

All Category, Case Studies, Regulatory /

Manufacturer of a very popular Menstrual Pain Patch with herbal ingredients wanted to introduce the product in USA. The product had herbal constituents sourced from India. With very strict US FDA requirements for importing and selling medicinal products in USA, the company wanted to have the right regulatory strategy, as the business opportunity was big.

Introduction of Indian Herbal Pain Patch in the USA Read More »

POM to P & GSL Switch

POM to P & GSL Switch – First Time for Molecule

All Category, Case Studies, Regulatory /

One of the top Indian multinational companies has been selling an antihistamine in the UK as Prescription Only Medicine (POM). DDReg was assigned with the task to assess the feasibility of change in the legal status of the product and thereafter support the regulatory strategy by way of developing safety rationale with regulatory documentation in

POM to P & GSL Switch – First Time for Molecule Read More »

Development of all-inclusive “Global” DMF

All Category, Case Studies, Regulatory /

Agencies across the emerging markets have been dealing with lot of ambiguities pertaining to Active Substance. These ambiguities emanate when a number of applicants submit diverse active substance information or Drug Master files (DMFs) on the same active by the same Active supplier (DMF Source). This usually happens when each applicant asks the API supplier

Development of all-inclusive “Global” DMF Read More »